Kirkland & Ellis advised Bristol Myers Squibb Company on the offering, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters....
Bristol Myers Squibb’s $4.5 Billion Notes Offering
Marsh McLennan’s $1.6 Billion Senior Notes Offering
Davis Polk & Wardwell advised Marsh McLennan, and Willkie Farr & Gallagher advised the joint book-running managers on the offering. Marsh McLennan (NYSE: MMC) announced it...
Editas Medicine’s $125 Million Shares Offering
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
Privia Health Group’s $936 Million Secondary Offering
Davis Polk advised Privia Health Group, Goodwin Procter advised the underwriter, Maples and Calder advised MBD 2013 Holdings and Bridge Street 2013 Holdings, while Mourant Ozannes...
Nikola’s $100 Million Follow-On Offerings
Pillsbury Winthrop advised Nikola, Davis Polk advised the underwriter and placement agent, and Milbank advised Antara Capital Master Fund LP. Nikola Corporation announced an SEC-registered public...
Marsh McLennan’s $600 Million Senior Notes Offering
Davis Polk advised Marsh McLennan, and Willkie Farr & Gallagher advised the underwriters. Marsh McLennan announced its SEC-registered offering of $600 million of its 5.450% senior...
Hamilton Lane’s $51.7 Million Follow-On Offering
Faegre Drinker advised Hamilton Lane, and Davis Polk advised the book-running manager for the offering. Hamilton Lane Incorporated announced the $51.7 million SEC-registered follow-on offering of...
Cigna’s $1.5 Billion Senior Notes Offering
Simpson Thacher advised The Cigna Group on the offering, and Davis Polk advised the representatives of the several underwriters involved. The Cigna Group announced the SEC-registered...
Assurant’s $175 Million Senior Notes Offering
Davis Polk advised Assurant, and Simpson Thacher advised the underwriters. Assurant, Inc. announced an SEC-registered offering of $175 million aggregate principal amount of 6.100% senior notes due...
CureVac’s $250 Million Common Shares Offering
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
Deciphera Pharmaceuticals’ $135.1 Million Common Stock Offering
Goodwin Procter advised Deciphera Pharmaceuticals, and Davis Polk advised the joint book-running managers involved in the offering. Deciphera Pharmaceuticals Inc. announced a $135.1 million SEC-registered common stock...
Biodesix’s $40 Million Shares Offering
Sidley Austin advised Biodesix, while Davis Polk & Wardwell advised the underwriter William Blair in the offering. Biodesix, Inc. executed the offering of 35,075,000 shares (including the...